Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center

摘要

Background and Aim: Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal cancers. Several local and systemic therapies are available for patients with HCC depending on the stage of the disease. In clinical practice, treatment decision-making, and sequencing may be very heterogeneous.